Back to top

Image: Bigstock

Is Ave Maria Growth Fund (AVEGX) a Strong Mutual Fund Pick Right Now?

Read MoreHide Full Article

On the lookout for a Mid Cap Growth fund? Starting with Ave Maria Growth Fund (AVEGX - Free Report) should not be a possibility at this time. AVEGX has a Zacks Mutual Fund Rank of 5 (Strong Sell), which is based on various forecasting factors like size, cost, and past performance.

Objective

We note that AVEGX is a Mid Cap Growth fund, and this area is also loaded with many different options. Companies are usually considered growth stocks when they consistently report notable sales and/or earnings growth. Thus, Mid Cap Growth funds pick stocks--usually companies with a market cap between $2 billion and $10 billion--that demonstrate extensive growth opportunities for investors compared to their peers.

History of Fund/Manager

Ave Maria is responsible for AVEGX, and the company is based out of Plymouth, MI. Ave Maria Growth Fund made its debut in May of 2003, and since then, AVEGX has accumulated about $1.19 billion in assets, per the most up-to-date date available. The fund's current manager, Adam Gaglio, has been in charge of the fund since July of 2019.

Performance

Of course, investors look for strong performance in funds. This fund has delivered a 5-year annualized total return of 8.85%, and it sits in the bottom third among its category peers. Investors who prefer analyzing shorter time frames should look at its 3-year annualized total return of 17.62%, which places it in the bottom third during this time-frame.

It is important to note that the product's returns may not reflect all its expenses. Any fees not reflected would lower the returns. Total returns do not reflect the fund's [%] sale charge. If sales charges were included, total returns would have been lower.

When looking at a fund's performance, it is also important to note the standard deviation of the returns. The lower the standard deviation, the less volatility the fund experiences. Over the past three years, AVEGX's standard deviation comes in at 14.55%, compared to the category average of 16.23%. The fund's standard deviation over the past 5 years is 17.9% compared to the category average of 19.49%. This makes the fund less volatile than its peers over the past half-decade.

Risk Factors

The fund has a 5-year beta of 1.08, so investors should note that it is hypothetically more volatile than the market at large. Alpha is an additional metric to take into consideration, since it represents a portfolio's performance on a risk-adjusted basis relative to a benchmark, which in this case, is the S&P 500. Over the past 5 years, the fund has a negative alpha of -4.74. This means that managers in this portfolio find it difficult to pick securities that generate better-than-benchmark returns.

Expenses

Costs are increasingly important for mutual fund investing, and particularly as competition heats up in this market. And all things being equal, a lower cost product will outperform its otherwise identical counterpart, so taking a closer look at these metrics is key for investors. In terms of fees, AVEGX is a no load fund. It has an expense ratio of 0.91% compared to the category average of 0.93%. From a cost perspective, AVEGX is actually cheaper than its peers.

While the minimum initial investment for the product is $2,500, investors should also note that there is no minimum for each subsequent investment.

Fees charged by investment advisors have not been taken into consideration. Returns would be less if those were included.

Bottom Line

Overall, even with its comparatively weak performance, average downside risk, and lower fees, Ave Maria Growth Fund ( AVEGX ) has a low Zacks Mutual Fund rank, and therefore looks a somewhat weak choice for investors right now.

For additional information on the Mid Cap Growth area of the mutual fund world, make sure to check out www.zacks.com/funds/mutual-funds. There, you can see more about the ranking process, and dive even deeper into AVEGX too for additional information. Zacks provides a full suite of tools to help you analyze your portfolio - both funds and stocks - in the most efficient way possible.

Published in